AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Latest Episodes
Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
The Role of Neuroimaging in Diagnosis of Alzheimer Disease
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
Evidence Review of FDA-Approved Monoclonal Antibody Treatments